NORBERT GLEICHER
Medical Practice at 69 St, New York, NY
License number
Florida 123382
Issued Date
Mar 18, 2015
Effective Date
Mar 18, 2015
Expiration Date
Jan 31, 2019
Category
Health Care
Type
Medical Doctor
Address
Address
21 E 69Th St, New York, NY 10021
Phone
(212) 994-4400
Organization information
See more information about NORBERT GLEICHER at bizstanding.comAmerican Infertility of New York, PC
21 E 69 St, New York, NY 10021
Industry:
Medical Doctor's Office
Doing business as:
Center for Human Reproduction<br>American Infertility - Norbert Gleicher MD<br>American Infertility of New York, P.C.
Phone:
(212) 994-4400 (Phone)
Medical Receptionists:
Jolanta Tapper (Manager),Sobelia Dorota (Ivf Coordinator),David H. Barad (Endocrinology, Medical Doctor),...
SIC6:
801105 - Physicians & Surgeons-Emergency Service
Categories:
Family & General Practice Physicians & Surgeons, Physicians & Surgeons
Company size:
15
Norbert Gleicher MD
21 E 69 St, New York, NY 10021
Industry:
Endocrinologist, Obgyn
Phone:
(212) 994-4400 (Phone)
Norbert Gleicher
Professional information
Founder &Amp; Medical Director At Center For Human Reproduction
Position:
Founder & Medical Director at Center for Human Reproduction
Location:
Greater New York City Area
Industry:
Medical Practice
Work:
Center for Human Reproduction
since 1981
-
Founder & Medical Director
Yale University School of Medicine
2003 - 2011
-
Vis. Professor of Obstetrics and Gynecology
New York University
2000 - 2002
-
Adj. Clinical Professor of Obstetrics and Gynecology, School of Medicine
University of Illinois at Chicago
1996 - 1999
-
Clinical Professor of Obstetrics and Gynecology
The University of Health Sciences/Chicago Medical School
1991 - 1996
-
Professor
Rush University Medical Center
1981 - 1990
-
Professor
Mount Sinai Hospital Medical Center of Chicago
1975 - 1979
-
Chief Resident/Assistant Professor
Ihilov Municipal Hospital
1973 - 1974
-
Intern
Education:
Tel Aviv University 1970 - 1973
M.D., Medicine Universität Wien 1966 - 1970
BS, Medicine
M.D., Medicine Universität Wien 1966 - 1970
BS, Medicine
Dr. Norbert Gleicher, New York NY - MD (Doctor of Medicine)
Specialties:
Obstetrics & Gynecology
Address:
Center Human Reproduction
21 E 69Th St, New York 10021
(212) 994-4400 (Phone)
21 E 69Th St, New York 10021
(212) 994-4400 (Phone)
Certifications:
Obstetrics & Gynecology
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Center Human Reproduction
21 E 69Th St, New York 10021
Yale - New Haven Hospital
20 York St, New Haven 06510
21 E 69Th St, New York 10021
Yale - New Haven Hospital
20 York St, New Haven 06510
Education:
Medical School
Sackler School Of Medicine, Tel Aviv University
Graduated: 1975
Ihilov Mun Hosp
Mount Sinai Hospital
Sackler School Of Medicine, Tel Aviv University
Graduated: 1975
Ihilov Mun Hosp
Mount Sinai Hospital
Norbert Gleicher, New York NY
Specialties:
OB-GYN
Address:
21 E. 69Th Street, New York, NY 10021
Languages:
English, German, Hebrew
Hospital affiliations:
Lenox Hill Hospital
Androgen Treatment In Females
US Patent:
2014003, Feb 6, 2014
Filed:
Jun 28, 2013
Appl. No.:
13/929993
Inventors:
Norbert Gleicher - New York NY, US
David H. Barad - Closter NJ, US
Dwyn V. Harben - Bryn Mawr PA, US
David H. Barad - Closter NJ, US
Dwyn V. Harben - Bryn Mawr PA, US
International Classification:
A61K 31/5685, A61K 31/568
US Classification:
514178
Abstract:
Method of using an androgen, such as dehydroepiandrosterone (DHEA) or testosterone, to improve human folliculogenesis. The method includes measuring a baseline follicle stimulating hormone (FSH) level of the human female, and when the baseline FSH level is below about 40.0 mIU/ml, administering about 75 milligrams of the androgen per day to the female for at least four months to treat ovarian follicles in at least one ovary of the female to improve human folliculogenesis during the at least four months. The present invention further is directed to a method of restoring the ovarian environment of an older human female to that of a younger human female. The method includes administering about 75 milligrams of an androgen per day to the female for at least four months.
Androgen Treatment In Females
US Patent:
2014001, Jan 9, 2014
Filed:
Jun 27, 2013
Appl. No.:
13/929134
Inventors:
Norbert Gleicher - New York NY, US
David H. Barad - Closter NJ, US
Dwyn V. Harben - Bryn Mawr PA, US
David H. Barad - Closter NJ, US
Dwyn V. Harben - Bryn Mawr PA, US
International Classification:
A61K 31/5685
US Classification:
514178
Abstract:
Method of improving ovarian reserve in a human female with diminished ovarian reserve as measured by the female's anti-Müllerian hormone level. The method may include evaluating a first anti-Müllerian hormone level of the female, administering an androgen, such as dehydroepiandrosterone or testosterone, to the female for at least about one month, and then evaluating a second anti-Müllerian hormone level of the female. Change in the anti-Müllerian hormone level is indicative of change in the ovarian reserve, e.g., when the second anti-Müllerian hormone level is greater than the first anti-Müllerian hormone level, the ovarian reserve has improved. The androgen administration may continue until the second anti-Müllerian hormone level is greater than the first anti-Müllerian hormone level by a desired percentage or amount.